Today, the American Diabetes Association® (ADA) announced the awardees of the 2025 Pathway to Stop Diabetes® (Pathway) grants ...

The distinct population of endothelial cells that line blood vessels in the insulin-producing "islets" of the human pancreas ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Though generally stable in healthy individuals, keeping an eye on the behaviour of blood sugar levels can reveal a great deal ...

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Experts are now calling for NHS guidance - which does not recommend managing diabetes with different drugs depending on age - ...

A small percentage have had vision problems, but a direct causal link with the drugs has not been established.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

Recent price cuts by major insulin manufacturers may appear to address affordability challenges, but they primarily target older insulin drugs nearing patent expiration. This tactic, coupled with the ...

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...